Incannex Healthcare stock tumbles after filing $100M offering
On Thursday, Lasertec Corp . (TYO:6920:JP) (OTC:LSRCF) received an upgraded stock rating from CLSA analysts. The rating was raised to High-Conviction Outperform from Outperform, accompanied by an increase in the price target to ¥24,900 from ¥22,400.
The analysts expect a recovery in orders starting from calendar year 2026. This recovery is anticipated to become evident in the company’s upcoming full-year earnings results, which are scheduled to be announced in August. The company’s ACTIS system is projected to benefit from the expansion of wafer fabrication locations, particularly in the United States, and further technological advancements into sub-2nm processes.
The CLSA analysts have forecasted operating profit for fiscal years 2025 to 2027, which are above the consensus estimates. They believe that Lasertec’s system will be crucial for inspecting pellicle-attached photomasks as technology migrates into finer inspection requirements.
The decision to upgrade the stock rating and raise the price target reflects the analysts’ view of greater potential returns for Lasertec. The company’s strategic positioning in the semiconductor inspection market is seen as a key factor in its future growth.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.